97041 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Receptors; Cell surface antigens; Cell surface determinants Integrin superfamily
Sub-classes:GENETICALLY ENGINEERED CELLS AND USES THEREOF
#2VEGFR FUSION PROTEIN PHARMACEUTICAL COMPOSITION
#3MODIFIED INTEGRIN POLYPEPTIDES, MODIFIED INTEGRIN POLYPEPTIDE DIMERS, AND USES THEREOF
#4CHIMERIC ENGULFMENT RECEPTOR MOLECULES
#5ANTIBODY-NKG2D LIGAND DOMAIN FUSION PROTEIN
#6ANTI-FIBROTIC TISSUE RESIDENT MEMORY T CELLS AND USES THEREOF
#7A4B7 THIOETHER PEPTIDE DIMER ANTAGONISTS
#8INDIRECT HOMOGENEOUS MOBILITY SHIFT ASSAYS FOR THE DETECTION OF BIOLOGICS IN PATIENT SAMPLES
#9MODIFIED INTEGRIN POLYPEPTIDES, MODIFIED INTEGRIN POLYPEPTIDE DIMERS, AND USES THEREOF
#10BI-TERMINAL PEGYLATED INTEGRIN-BINDING PEPTIDES AND METHODS OF USE THEREOF
#11METHODS AND COMPOSITIONS FOR THE TREATMENT OF WOUNDS
#12Polypeptide Integrin Antagonists
#13Integrin binding peptides and uses thereof
#14METHODS FOR TREATING DRUG RESISTANT CANCERS
#15PROTEIN SUBSTRATE TO BIND GROWTH FACTOR
#16VEGFR fusion protein pharmaceutical composition
#17IMMOBILIZED SELF-ASSEMBLED PROTEIN MULTIMERS
#18NANO-LIGAND FOR PROMOTING CELL ADHESION AND DIFFERENTIATION OF STEM CELLS AND METHOD OF PROMOTING CELL ADHESION AND DIFFERENTIATION OF STEM CELLS BY USING THE SAME
#19SELECTION OF IMPROVED TUMOR REACTIVE T-CELLS
#20THERAPEUTIC FUSION PROTEINS
#21METHODS OF DETECTING AND TREATING LUNG DAMAGE IN RESPIRATORY-RELATED VIRAL INFECTIONS
#22Polypeptide integrin antagonists
#23CHIMERIC PROTEINS IN AUTOIMMUNITY
#24Engineered platelets for targeted delivery of a therapeutic agent
#25MURINE MODEL OF FETAL/NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
#26DUAL CHIMERIC ANTIGEN RECEPTOR TARGETING EPCAM AND ICAM-1
#27NANOCOIL-SUBSTRATE COMPLEX FOR CONTROLLING STEM CELL BEHAVIOR, PREPARATION METHOD THEREOF, AND METHOD OF CONTROLLING ADHESION AND DIFFERENTIATION OF STEM CELL BY USING THE SAME
#28Chimeric engulfment receptor molecules
#29Integrin antagonists
#30MODIFIED INTEGRIN POLYPEPTIDES, MODIFIED INTEGRIN POLYPEPTIDE DIMERS, AND USES THEREOF
#31B1SP Fusion Protein Therapeutics, Methods, and Uses
#32Engineered platelets for targeted delivery of a therapeutic agent
#33Composition and Method for Regulating Migration of Immune Cells
#34BI-FUNCTIONAL ARGININE-GLYCINE-ASPARTIC ACID (RGD) PEPTIDES AND METHODS TO PROMOTE ANGIOGENESIS
#35α4β7 thioether peptide dimer antagonists
#36CHIMERIC RECEPTORS TO STEAP1 AND METHODS OF USE THEREOF
#37Nano-ligand for promoting cell adhesion and differentiation of stem cells and method of promoting cell adhesion and differentiation of stem cells by using the same
#38CAR-T LYMPHOCYTES ENGINEERED TO HOME TO LYMPH NODE B CELL ZONE, SKIN, OR GASTROINTESTINAL TRACT
#39Bi-terminal pegylated integrin-binding peptides and methods of use thereof
#40Compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions
#41Murine model of fetal/neonatal alloimmune thrombocytopenia
#42Inhibitors of β integrin-G protein α subunit binding interactions
#43Methods and compositions for the treatment of wounds
#44METHODS AND SYSTEMS FOR IDENTIFICATION AND TREATMENT OF PATHOLOGICAL NEURODEGENERATION AND AGE-RELATED COGNITIVE DECLINE
#45Methods and compositions for diagnosing and treating diseases
#46NOVEL a4B7 THIOETHER PEPTIDE DIMER ANTAGONISTS
#47CHIMERIC ANTIGEN RECEPTORS SPECIFIC TO AVB6 INTEGRIN AND METHODS OF USE THEREOF TO TREAT CANCER
#48POLYPEPTIDE WITH TUMOUR BINDING ACTIVITY
#49Indirect homogeneous mobility shift assays for the detection of biologics in patient samples
#50CHIMERIC ENGULFMENT RECEPTOR MOLECULES
#51Modified integrin polypeptides, modified integrin polypeptide dimers, and uses thereof
#52IMMUNE SYSTEM MODULATORS
#53NOVEL a4ß7 PEPTIDE DIMER ANTAGONISTS
#54Nanocage and use thereof
#55Vesicles comprising lectins expressed on the surface and methods of use thereof to deliver an agent to autophagic and apoptotic cells
#56Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof
#57Inhibitors of beta integrin-G protein alpha subunit binding interactions
#58α4β7 thioether peptide dimer antagonists
#59COMPOUNDS FOR USE IN THE TREATMENT OF TELOMERE RELATED DISEASES AND/OR TELOMERE RELATED MEDICAL CONDITIONS
#60Integrin binding peptides and uses thereof
#61Suppression of SPLA2-integrin binding for treating an inflammatory condition or suppressing cell proliferation
#62B1SP fusion protein therapeutics, methods, and uses
#63Bi-functional arginine-glycine-aspartic acid (RGD) peptides and methods to promote angiogenesis
#64CD 47 CONTAINING POROUS NANOPARTICLE SUPPORTED LIPID BILAYERS (PROTOCELLS) FIELD OF THE INVENTION
#65Cyclic monomer and dimer peptides having integrin antagonist activity
#66α4β7 thioether peptide dimer antagonists
#67CAR-T LYMPHOCYTES ENGINEERED TO HOME TO LYMPH NODE B CELL ZONE, SKIN, OR GASTROINTESTINAL TRACT
#68INTEGRIN HETERODIMER AND A SUBUNIT THEREOF
#69METHODS OF DETECTING INFLAMMATORY MARKERS AND TREATING INFLAMMATORY CONDITIONS IN HUMANS
#70CHIMERIC PROTEIN
#71Indirect homogeneous mobility shift assays for the detection of biologics in patient samples
#72Methods for synthesizing α4β7 peptide antagonists
#73Immune system modulators
#74Multivalent fibronectin-integrin binding compositions and methods of use thereof
#75CHIMERIC ANTIGEN RECEPTORS SPECIFIC TO AVB6 INTEGRIN AND METHODS OF USE THEREOF TO TREAT CANCER
#76Modified integrin polypeptides, modified integrin polypeptide dimers, and uses thereof
#77Bi-terminal pegylated integrin-binding peptides and methods of use thereof
#78Integrin heterodimer and a subunit thereof
#79NOVEL a4B7 PEPTIDE DIMER ANTAGONISTS
#80Immune system modulators
#81Inhibitors of beta integrin-G protein alpha subunit binding interactions
#82STABILIZED LOW AFFINITY CONFORMATION OF INTEGRINS FOR DRUG DISCOVERY
#83a4B7 integrin thioether peptide antagonists
#84Methods and agents for the treatment of cancer
#85Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof
#86Antimicrobial peptide and use thereof
#87Peptide agents for cancer therapy
#88CHAPERONE-BASED INTEGRIN INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES
#89Antibodies that bind integrin alpha-V beta-8
#90Inhibitors of beta integrin-G protein alpha subunit binding interactions
#91METHOD OF MODULATING INTEGRIN MEDIATED CELLULAR ACTIVITY AND AGENTS USEFUL FOR SAME
#92SOLUBLE INTEGRIN ALPHA-4 MUTANT
#93METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING DISEASES
#94Bladder cancer tumor marker, antibody and use thereof
#95Integrin heterodimer and a subunit thereof
#96Inhibitors of beta integrin-G protein alpha subunit binding interactions
#97INHIBITION OF LEUKOCYTE ADHESION
#98INHIBITION OF MULTIPLE CELL ACTIVATION PATHWAYS
#99Method of modulating integrin mediated cellular activity and agents useful for same
#100Method for producing proteins in that lack detectable cross binding activity to antibodies against host cell antigens
#101Integrin Heterodimer And A Subunit Thereof
#102INTEGRIN HETERODIMER AND AN ALPHA SUBUNIT THEREOF
#103Modified polypeptides stabilized in a desired conformation and methods for producing same
#104Methods and compositions for diagnosing and treating diseases
#105Use of Agonists of Integrin Alpha 5 for Inducing the Osteogenic Differentiation of Mesenchymal Stem Cells
#106Set of Antiangiogenic Molecules and Use Thereof
#107SENESCENCE CONTROL COMPOSITION CONTAINING EXTRACELLULAR MATRIX COMPONENTS, AND SENESCENCE CONTROL METHOD FOR SENESCENT CELLS USING SAME
#108Cytotoxic T-Lymphocyte-Inducing Immunogens for Prevention, Treatment and Diagnosis of Cancer
#109Modified polypeptides stabilized in a desired conformation and methods for producing same
#110Marker for stem cells and its use
#111Polypeptides Selective for alphavbeta3 Integrin Conjugated With a Variant Of Human Serum Albumin (HSA) And Pharmaceutical Uses Thereof
#112Peptide-based compounds
#113Peptidic antagonists of class III semaphorins/neuropilins complexes
#114Stabilized low affinity conformation of integrins for drug discovery
#115NOVEL RECEPTOR FOR CD40L AND USES THEREOF
#116Modified polypeptides stabilized in a desired conformation and methods for producing same
#117USE OF INTEGRIN ALPHA 10 BINDING ANTIBODY TO MODULATE EXTRACELLULAR MATRIX (CARTILAGE) TURNOVER
#118DETECTION OF HUMAN PLATELET ANTIGEN (HPA) ANTIBODIES
#11912 human secreted proteins
#120Peptide-based compounds
#121Methods of expressing integrin beta6 subunits
#122BETA INTEGRIN GENE AND PROTEIN
#123Integrin Heterodimer and an Alpha Subunit Thereof
#124Peptides and methods for the treatment of inflammatory disease
#125Novel peptides and methods for the treatment of inflammatory disorders
#126Integrin-binding antibodies
#127Integrin alpha L I domain mutants with increased binding affinity
#128Imaging compounds, methods of making imaging compounds, methods of imaging, therapeutic compounds, methods of making therapeutic compounds, and methods of therapy
#129Inhibition of leukocyte adhesion
#130Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
#131Methods and uses of the integrin alpha 10 chain, for preventing progression of atherosclerosis plaque formation
#132Peptide based-compounds
#133Methods and Agents for the Treatment of Cancer
#134Fluorescein-labelled peptides
#135Method for identifying an anti- streptococcal agent and its use for treating streptococcal infections
#136Method for producing a recombinant protein of interest and protein thus produced
#137Treatment of acute lung injury, fibrosis and metastasis with antagonists of αvβ6
#138Methods for controlling pathological angiogenesis by inhibition of a6b4 integrin
#139Antibody to an integrin heterodimer and/or a subunit thereof
#140Chimeric protein
#141Knockout mice and their use
#14212 human secreted proteins
#143Vectors and methods for gene transfer
#144Beta integrin gene and protein
#145Novel integrin alpha subunit and uses thereof
#146Modified polypeptides stabilized in a desired conformation and methods for producing same
#147Methods and uses of the integrin alpha 10 chain, for preventing progression of atherosclerosis plaque formation
#148Marker for stem cells and its use
#149Modified polypeptides stabilized in a desired conformation and methods for producing same
#150Methods of expressing integrin βsubunits
#151Oligomeric molecules and uses thereof
#152Methods of screening for compounds for treating muscular dystrophy using human ALPHA7 integrin mRNA translation regulation